Total Payments
$2,768
2024 Payments
$614.76
Companies
20
Transactions
61
Medicare Patients
4,993
Medicare Billing
$1.8M
Payment Breakdown by Category
Food & Beverage$1,818 (65.7%)
Research$950.20 (34.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,818 | 53 | 65.7% |
| Unspecified | $950.20 | 8 | 34.3% |
Payments by Type
General
$1,818
53 transactions
Research
$950.20
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | $950.20 | 8 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $372.44 | 13 | $0 (2024) |
| Allergan, Inc. | $285.82 | 10 | $0 (2020) |
| ABBVIE INC. | $178.95 | 6 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $166.67 | 2 | $0 (2024) |
| Alcon Laboratories Inc | $131.89 | 1 | $0 (2017) |
| Dutch Ophthalmic, USA | $117.65 | 1 | $0 (2019) |
| OPTOVUE, INC. | $113.55 | 1 | $0 (2017) |
| Alimera Sciences, Inc. | $53.34 | 2 | $0 (2024) |
| Astellas Pharma US Inc | $52.30 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $614.76 | 17 | Bausch & Lomb Americas Inc. ($166.67) |
| 2023 | $187.26 | 7 | Regeneron Healthcare Solutions, Inc. ($78.39) |
| 2022 | $72.09 | 4 | Oyster Point Pharma, Inc. ($42.52) |
| 2020 | $102.77 | 5 | Novartis Pharmaceuticals Corporation ($46.07) |
| 2019 | $1,361 | 18 | Regeneron Pharmaceuticals, Inc. ($950.20) |
| 2018 | $125.78 | 5 | Allergan Inc. ($111.30) |
| 2017 | $303.98 | 5 | Alcon Laboratories Inc ($131.89) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: EYE CARE | ||||||
| 12/17/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Ophthalmology | ||||||
| 09/12/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/01/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $34.66 | General |
| Category: EYE CARE | ||||||
| 07/19/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/18/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $49.11 | General |
| Category: Ophthalmology | ||||||
| 06/27/2024 | Halozyme Inc | HYLENEX RECOMBINANT (Biological) | Food and Beverage | In-kind items and services | $34.29 | General |
| Category: OPTHALMOLOGY | ||||||
| 06/08/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $33.73 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/23/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/13/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: EYE CARE | ||||||
| 05/09/2024 | Bausch & Lomb Americas Inc. | IC-8 Apthera IOL (Device), enVista MX60 IOL | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Ophthalmology | ||||||
| 04/06/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/05/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/15/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Ophthalmology | ||||||
| 03/07/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $32.34 | General |
| 01/25/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $34.23 | General |
| Category: Ophthalmology | ||||||
| 01/04/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $31.16 | General |
| Category: EYE CARE | ||||||
| 12/15/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/05/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: EYE CARE | ||||||
| 10/20/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $31.97 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/07/2023 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $30.06 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/06/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $33.12 | General |
| 06/30/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/03/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/01/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Immunology and Ophthalmology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Randomized, Controlled, Multi-Center Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity | Regeneron Pharmaceuticals, Inc. | $950.20 | 8 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,366 | 2,891 | $2.2M | $457,503 |
| 2022 | 15 | 1,371 | 2,733 | $1.8M | $500,144 |
| 2021 | 15 | 1,191 | 2,589 | $1.7M | $503,611 |
| 2020 | 16 | 1,065 | 2,274 | $1.4M | $375,202 |
Total Patients
4,993
Total Services
10,487
Medicare Billing
$1.8M
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 48 | 428 | $1.2M | $293,479 | 24.1% |
| 67028 | Injection of drug into eye | Office | 2023 | 98 | 434 | $281,542 | $43,295 | 15.4% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 295 | 439 | $195,794 | $38,186 | 19.5% |
| 92134 | Imaging of retina | Office | 2023 | 293 | 743 | $131,781 | $24,223 | 18.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 110 | 178 | $46,636 | $13,027 | 27.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 84 | $32,088 | $8,389 | 26.1% |
| 92250 | Photography of the retina | Office | 2023 | 223 | 258 | $74,046 | $7,982 | 10.8% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 16 | 27 | $87,912 | $7,962 | 9.1% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 32 | 109 | $26,596 | $6,093 | 22.9% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 47 | 47 | $24,910 | $5,119 | 20.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $17,460 | $4,221 | 24.2% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 24 | 24 | $12,408 | $2,842 | 22.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 40 | 50 | $8,334 | $1,279 | 15.3% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 19 | 20 | $5,160 | $945.31 | 18.3% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 18 | 20 | $3,800 | $460.72 | 12.1% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 46 | 484 | $1.1M | $349,010 | 32.5% |
| 67028 | Injection of drug into eye | Office | 2022 | 87 | 375 | $227,651 | $39,109 | 17.2% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 246 | 345 | $129,339 | $30,366 | 23.5% |
| 92134 | Imaging of retina | Office | 2022 | 253 | 565 | $102,452 | $19,662 | 19.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 109 | 132 | $39,504 | $13,912 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 99 | 163 | $33,054 | $12,055 | 36.5% |
| 92250 | Photography of the retina | Office | 2022 | 268 | 324 | $57,902 | $9,433 | 16.3% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2022 | 17 | 24 | $73,608 | $7,477 | 10.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $15,394 | $5,099 | 33.1% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 26 | 85 | $17,128 | $4,578 | 26.7% |
About Dr. Eric Shrier, D.O
Dr. Eric Shrier, D.O is a Ophthalmology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1720062037.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Shrier, D.O has received a total of $2,768 in payments from pharmaceutical and medical device companies, with $614.76 received in 2024. These payments were reported across 61 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,818).
As a Medicare-enrolled provider, Shrier has provided services to 4,993 Medicare beneficiaries, totaling 10,487 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Brooklyn, NY
- Active Since 11/30/2005
- Last Updated 08/12/2013
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1720062037
Products in Payments
- EYLEA (Biological) $1,113
- OZURDEX (Drug) $285.18
- EYLEA HD (Biological) $170.89
- IC-8 Apthera IOL (Device) $150.00
- EVA Ophthalmic Surgical System (Device) $117.65
- XR (Device) $113.55
- XIIDRA (Drug) $82.88
- HYDRUS Microstent (Device) $49.11
- TYRVAYA (Drug) $42.52
- EYLEA AFLIBERCEPT INJECTION (Biological) $38.40
- CEQUA (Drug) $35.10
- HYLENEX RECOMBINANT (Biological) $34.29
- Syfovre (Drug) $34.23
- ILUVIEN (Drug) $30.06
- VABYSMO (Drug) $29.57
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $28.31
- DURYSTA (Drug) $25.25
- YUTIQ (Drug) $23.28
- TEPEZZA (Biological) $19.99
- Vabysmo (Drug) $19.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Brooklyn
David Rubaltelli, M.d, M.D
Ophthalmology — Payments: $8.9M
Ophthalmology $8.9M
Dr. Irene Gladstein, M.d, M.D
Ophthalmology — Payments: $106,815
Ophthalmology $106,815
Mr. Raphael Rosenbaum, M.d, M.D
Ophthalmology — Payments: $40,149
Ophthalmology $40,149
Dr. Leonard Bley, M.d, M.D
Ophthalmology — Payments: $23,405
Ophthalmology $23,405
Dr. Bradley Phillips, M.d, M.D
Ophthalmology — Payments: $16,804
Ophthalmology $16,804
Joseph Zelefsky, Md, MD
Ophthalmology — Payments: $12,170
Ophthalmology $12,170